Jason T. Romancik

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook et al. · Blood · 2021 · 94 citations · Full text

Medicine, Oncology, Hematologic Oncology +4

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Reid W. Merryman, Luca Castagna, Laura Giordano et al. · Leukemia · 2021 · 80 citations

Life Sciences, Immunology, Oncology +13

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

Joanna Zurko, Imran Nizamuddin, Narendranath Epperla et al. · Blood Advances · 2022 · 50 citations · Full text

Life Sciences, Immunology, Oncology +14

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Reid W. Merryman, Robert Redd, Taiga Nishihori et al. · Blood Advances · 2021 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

David Qualls, Nicholas Lambert, Paolo F. Caimi et al. · Blood · 2023 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +13